VOYA Investment Management Portfolio holdings
AUM
$100B
1-Year Return
30.07%
This Quarter Return
+17.51%
1 Year Return
+30.07%
3 Year Return
+120.64%
5 Year Return
+214.86%
10 Year Return
+564.47%
AUM
$100B
AUM Growth
+$10.6B
(+12%)
Cap. Flow
-$9.65B
Cap. Flow
% of AUM
-9.61%
Top 10 Holdings %
Top 10 Hldgs %
26.3%
Holding
2,806
New
155
Increased
1,259
Reduced
1,080
Closed
127
Top Buys
| 1 |
Microsoft
MSFT
|
+$1.03B |
| 2 |
Boston Scientific
BSX
|
+$514M |
| 3 |
Caterpillar
CAT
|
+$387M |
| 4 |
Cisco
CSCO
|
+$366M |
| 5 |
Walt Disney
DIS
|
+$363M |
Top Sells
| 1 |
Salesforce
CRM
|
+$504M |
| 2 |
Palantir
PLTR
|
+$326M |
| 3 |
CrowdStrike
CRWD
|
+$291M |
| 4 |
Bank of America
BAC
|
+$277M |
| 5 |
Cadence Design Systems
CDNS
|
+$264M |
Sector Composition
| 1 | Technology | 33.81% |
| 2 | Financials | 9.82% |
| 3 | Consumer Discretionary | 8.14% |
| 4 | Healthcare | 8.11% |
| 5 | Industrials | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1101
CarGurus
CARG
$3.51B
| $2.59M | ﹤0.01% |
77,465
+53,140
| +218% | +$1.78M |
|
1102
BioNTech
BNTX
$25.1B
| $2.58M | ﹤0.01% |
24,235
-3,635
| -13% | -$387K |
|
1103
John B. Sanfilippo & Son
JBSS
$724M
| $2.58M | ﹤0.01% |
+40,753
| New | +$2.58M |
|
1104
GitLab
GTLB
$8.17B
| $2.58M | ﹤0.01% |
57,100
-376,775
| -87% | -$17M |
|
1105
Lattice Semiconductor
LSCC
$9.06B
| $2.57M | ﹤0.01% |
52,521
-817,712
| -94% | -$40.1M |
|
1106
Tandem Diabetes Care
TNDM
$836M
| $2.57M | ﹤0.01% |
137,749
+1,051
| +0.8% | +$19.6K |
|
1107
Ionis Pharmaceuticals
IONS
$10.2B
| $2.55M | ﹤0.01% |
64,517
+750
| +1% | +$29.6K |
|
1108
Houlihan Lokey
HLI
$14.1B
| $2.54M | ﹤0.01% |
14,118
+4,303
| +44% | +$774K |
|
1109
Mattel
MAT
$5.78B
| $2.53M | ﹤0.01% |
128,393
+16,424
| +15% | +$324K |
|
1110
Radian Group
RDN
$4.73B
| $2.53M | ﹤0.01% |
70,148
+10,795
| +18% | +$389K |
|
1111
iShares Russell Top 200 Value ETF
IWX
$2.83B
| $2.53M | ﹤0.01% |
29,994
-8,614
| -22% | -$725K |
|
1112
Innodata
INOD
$1.94B
| $2.52M | ﹤0.01% |
49,268
+41,978
| +576% | +$2.15M |
|
1113
Churchill Downs
CHDN
$6.77B
| $2.52M | ﹤0.01% |
24,955
-262,234
| -91% | -$26.5M |
|
|
ONC
1114
BeOne Medicines Ltd. American Depositary Shares
ONC
$34.5B
| $2.51M | ﹤0.01% |
10,385
| – | – |
|
1115
Simply Good Foods
SMPL
$2.73B
| $2.51M | ﹤0.01% |
79,403
-300
| -0.4% | -$9.48K |
|
1116
Intellia Therapeutics
NTLA
$1.23B
| $2.51M | ﹤0.01% |
267,061
+59,052
| +28% | +$554K |
|
1117
Prestige Consumer Healthcare
PBH
$3.2B
| $2.5M | ﹤0.01% |
31,362
-10,355
| -25% | -$827K |
|
1118
Banner Corp
BANR
$2.3B
| $2.5M | ﹤0.01% |
39,001
-476
| -1% | -$30.5K |
|
1119
89bio
ETNB
$1.26B
| $2.5M | ﹤0.01% |
254,256
+121,465
| +91% | +$1.19M |
|
1120
Graco
GGG
$14.1B
| $2.49M | ﹤0.01% |
29,020
-2,530
| -8% | -$218K |
|
1121
Darling Ingredients
DAR
$4.95B
| $2.49M | ﹤0.01% |
65,707
+26,284
| +67% | +$997K |
|
1122
Patterson-UTI
PTEN
$2.11B
| $2.49M | ﹤0.01% |
419,617
-10,430
| -2% | -$61.9K |
|
1123
Travere Therapeutics
TVTX
$2.43B
| $2.48M | ﹤0.01% |
167,721
+44,812
| +36% | +$663K |
|
1124
Artisan Partners
APAM
$3.27B
| $2.47M | ﹤0.01% |
55,651
-8,547
| -13% | -$379K |
|
1125
Cushman & Wakefield
CWK
$3.7B
| $2.46M | ﹤0.01% |
222,117
-2,076
| -0.9% | -$23K |
|